Nutritional Aspect of Cancer Care in Medical Oncology Patients
dc.contributor.author | Yalcin, Suayib | |
dc.contributor.author | Gumus, Mahmut | |
dc.contributor.author | Oksuzoglu, Berna | |
dc.contributor.author | Ozdemir, Feyyaz | |
dc.contributor.author | Evrensel, Turkkan | |
dc.contributor.author | Sarioglu, Aysugul Alptekin | |
dc.contributor.author | Goker, Erdem | |
dc.date.accessioned | 2020-12-01T12:06:33Z | |
dc.date.available | 2020-12-01T12:06:33Z | |
dc.date.issued | 2019 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Purpose: Awareness of advances in the nutritional aspects of cancer care and translation of this information into clinical practice are important for oncology practitioners to effectively couple oncologic and nutritional approaches throughout the cancer journey. the goal of this consensus statement by a panel of medical oncologists was to provide practical and implementable guidance addressing nutritional aspects of cancer care from the perspective of the medical oncologist. Methods: A panel of medical oncologists agreed on a series of statements supported by scientific evidence and expert clinical opinion. Findings: Participating experts emphasized that both poor nutritional intake and metabolic alterations underlie cancer-related malnutrition. the use of liquid and high energy-dense oral nutritional supplements may enable better patient compliance, whereas higher efficacy is more likely with the use of pharmaconutrient-enriched oral nutritional supplements in terms of improved weight, lean body mass, functional status, and quality of life, as well as better tolerance to antineoplastic treatment. A multimodal approach is currently believed to be the best option to counteract the catabolism leading to cancer-related malnutrition; this treatment is scheduled in parallel with anticancer therapies and includes nutritional interventions, multitarget drug therapies, and exercise and rehabilitation programs. Participating experts emphasized the role of the oncologist as a reference professional figure in the coordination of nutritional care for patients with cancer within the context of complex and different clinical scenarios, particularly for permissive-adjunctive nutritional support. (C) 2019 the Authors. Published by Elsevier Inc. | en_US |
dc.description.sponsorship | Abbott Turkey | en_US |
dc.description.sponsorship | The present study was supported by Abbott Turkey which played a role in organization of expert panel meetings including invitation of participants and compensation for the time and transport expenses of the experts. Abbott had no influence on selection of the experts. Abbott had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors contributed equally to the preparation of the article in terms of developing a consensus opinion on the nutritional aspects of cancer care from the medical oncologists' perspective, including critical analysis of recommendations from international guidelines, systemic reviews and meta-analyses, and published results of randomized controlled trials, and identification of a series of statements supported by scientific evidence and experts' clinical opinion. All authors contributed equally to the drafting of the manuscript, and all read and approved the final manuscript. Dr. Yalcin agreed to be fully accountable for ensuring the integrity and accuracy of the work and had primary responsibility for final content on behalf of the Turkey Medical Oncology Active Nutrition Platform. | en_US |
dc.identifier.doi | 10.1016/j.clinthera.2019.09.006 | en_US |
dc.identifier.endpage | 2396 | en_US |
dc.identifier.issn | 0149-2918 | |
dc.identifier.issn | 1879-114X | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | 31699437 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 2382 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.clinthera.2019.09.006 | |
dc.identifier.uri | https://hdl.handle.net/11454/63242 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000503107700016 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Clinical Therapeutics | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cancer cachexia | en_US |
dc.subject | cancer patients | en_US |
dc.subject | nutritional screening | en_US |
dc.subject | nutritional support | en_US |
dc.subject | medical oncologist's perspective | en_US |
dc.subject | treatment | en_US |
dc.title | Nutritional Aspect of Cancer Care in Medical Oncology Patients | en_US |
dc.type | Review Article | en_US |